Patient
(NLQ): asymptomatic, 7 year old girl, 29 kg. weight. Scheduled ultrasound detected Cadastre in the town of Ramos Mexia (río Negro Southern Line) in January 2007.
(NLQ): asymptomatic, 7 year old girl, 29 kg. weight. Scheduled ultrasound detected Cadastre in the town of Ramos Mexia (río Negro Southern Line) in January 2007. We do not have the first image of the liver hydatid cyst (conducted during the land), it was a HCL 5.5 cm in diameter -Gharbi Type I-. 10/01/2007
The following laboratory studies (20% eosinophils) and normal chest radiograph, began chemotherapy with albendazole (ABZ) (15mg/kg/día): One tablet of 400 mg per day (Made in Public Health PROZOME Black River) for three months with a rest period of 15 days upon completion of the first and second month of treatment. Controls were run according to rules governing the province.
The following laboratory studies (20% eosinophils) and normal chest radiograph, began chemotherapy with albendazole (ABZ) (15mg/kg/día): One tablet of 400 mg per day (Made in Public Health PROZOME Black River) for three months with a rest period of 15 days upon completion of the first and second month of treatment. Controls were run according to rules governing the province.
This first ultrasound dated 02/09/2007 (one month after starting therapy with ABZ) shows an HCL paravesicular of 52.6 mm in diameter with detachment of the germinative membrane without altering the content (Gharbi type II).
Gharbi type II (detail) 
Gharbi Type II (09-02-2007) 
Gharbi type II (detail) 
Gharbi type II (12/03/2007) The clinical and laboratory upon completion of the second month of treatment was detected gastric intolerance (epigastric pain) and a decrease of eosinophilia to 2% of the formula. Ranitidine 300mg/day was associated to ABZ.
The ultrasound image is seen: a total membrane folding germination no changes in the density of the liquid.
Gharbi type II (detail) 
Gharbi type II to IV (30/04/2007) asymptomatic patient who continues to start the third month of chemotherapy (30 - 2004-2007). In the ultrasound image can be observed: dissolution of the germinative membrane and marked changes in the density of the liquid contents (Gharbhi positive development of a Type II to Type IV).
Gharbi type II to IV (detail) 
Gharbi type IV (04/06/2007) ABZ treatment ended, he continued asymptomatic and unaltered the laboratory results.
Gharbi type IV (detail) 
Gharbi type IV (07/12/2007) 
Gharbi type IV (detail) 
Gharbi type IV (12-07-2007) 
Gharbi type IV (detail) 
Gharbi Tipo IV (01-11-2007) Control ecográfico a los 10 meses de iniciado el tratamiento: presenta imágen del QHH deformada y disminuida de tamaño (42,6 mm diametro mayor); con contenido densidad heterogenea.
Gharbi Tipo IV (detalle) 
Gharbi Tipo IV -42,6 mm diámetro- (detalle) 
Gharbi Tipo IV (11-07-2008) Imágen del control ecográfico realizado a los 18 meses de iniciado the treatment: almost homogeneous density, semi-and reduced upper diameter (37 mm).
Gharbi type IV (detail)
Gharbi type IV (11/07/2008)
Gharbi type IV ( detail)
Last
Gharbi type IV (detail) 
Gharbi type IV (11/07/2008) 
Gharbi type IV ( detail) Last
control (11-07-2008) , remains without symptoms and without changes in laboratory results. The follow-up ultrasound studies were performed with abdominal and chest X-ray every 6 months to age 3 starting treatment.
